NFG
PLRX icon

Next Financial Group’s Pliant Therapeutics PLRX Stock Holding History

Next Financial Group’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$0 Hold
20
– – ﹤0.01% 2943
2021
Q3 		$0 Hold
20
– – ﹤0.01% 2799
2021
Q2 		$1K Hold
20
– – ﹤0.01% 2550
2021
Q1 		$1K Hold
20
– – ﹤0.01% 2445
2020
Q4 		$0 Hold
20
– – ﹤0.01% 2400
2020
Q3 		$0 Buy
+20
New +$500 ﹤0.01% 2206

Other funds holding PLRX

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Next Financial Group's PLRX Position: Q4 2021 in Review

Next Financial Group held its Pliant Therapeutics (PLRX) position steady in Q4 2021 at 20 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2943.

Next Financial Group first reported a position in PLRX in Q3 2020 and has held it in 6 quarters since. The position peaked at $1K in Q2 2021. 88 funds tracked by Wall St. Rank hold PLRX as of Q4 2021.

  • Next Financial Group held 20 shares of Pliant Therapeutics worth $0 as of Q4 2021.
  • Next Financial Group left its Pliant Therapeutics share count unchanged in Q4 2021.
  • Pliant Therapeutics made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2943 holding.
  • Next Financial Group first reported a position in Pliant Therapeutics in Q3 2020 and has held it in 6 quarters since.
  • Next Financial Group's Pliant Therapeutics position peaked at $1K in Q2 2021.
  • 88 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.